Literature DB >> 3379619

The prevalence of rheumatoid arthritis in a rural African population.

S W Brighton1, A L de la Harpe, D J van Staden, J H Badenhorst, O L Myers.   

Abstract

We report the findings of an epidemiological study of the prevalence of rheumatoid arthritis (RA) in a rural population. The study was conducted in Venda, a very remote part of South Africa. Much of the population still follows an age old traditional lifestyle. A detailed hut-to-hut survey of 543 respondents comprising 97% of the population of one village was conducted. This included clinical, serological and radiological studies. This was supplemented by questioning local traditional doctors and showing them photographs of typical hand deformities to ascertain if they knew of any cases with these deformities. The 3 hospitals draining the area were also surveyed. The detailed survey of 543 respondents revealed no cases of definite or probable RA using a modification of the Rome criteria. No cases were recognized by the traditional doctors. The 3 hospitals together had 14 cases of definite RA out of a population of about 520,000. This gave a prevalence of 0.0026%. The marked difference in the prevalence of RA in this population as opposed to other Southern African studies as well as American and European studies is discussed.

Entities:  

Mesh:

Year:  1988        PMID: 3379619

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  27 in total

Review 1.  Polygenic susceptibility in rheumatoid arthritis.

Authors:  P Wordsworth; J Bell
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

Review 2.  Human Leukocyte Antigen-Disease Associations in Rheumatoid Arthritis.

Authors:  Vincent van Drongelen; Joseph Holoshitz
Journal:  Rheum Dis Clin North Am       Date:  2017-08       Impact factor: 2.670

Review 3.  Rheumatoid arthritis in sub-Saharan Africa.

Authors:  P McGill
Journal:  Ann Rheum Dis       Date:  1991-12       Impact factor: 19.103

4.  Is rheumatoid arthritis an infectious disease?

Authors:  A J Silman
Journal:  BMJ       Date:  1991-07-27

5.  HLA-DR gene frequencies in a Zaïrean population with particular reference to rheumatic diseases.

Authors:  K Mbayo; J M Mbuyi-Muamba; L Hallé; D Salmon; C Martageix; F Castellano; C Kaplan; Z Lurhuma
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

6.  The prevalences of some rheumatic diseases in western Turkey: Havsa study.

Authors:  Necati Cakır; Ömer Nuri Pamuk; Emine Derviş; Neşe Imeryüz; Haşim Uslu; Ömer Benian; Edip Elelçi; Genco Erdem; Fatma Oğuz Sarvan; Mustafa Senocak
Journal:  Rheumatol Int       Date:  2011-01-13       Impact factor: 2.631

7.  Prevalence and incidence of rheumatoid arthritis in South Korea.

Authors:  Yoon-Kyoung Sung; Soo-Kyung Cho; Chan-Bum Choi; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2012-12-20       Impact factor: 2.631

8.  Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients.

Authors:  Madeleine Singwe-Ngandeu; Axel Finckh; Sylvette Bas; Jean-Marie Tiercy; Cem Gabay
Journal:  Arthritis Res Ther       Date:  2010-03-02       Impact factor: 5.156

9.  The prevalence and functional impact of musculoskeletal conditions amongst clients of a primary health care facility in an under-resourced area of Cape Town.

Authors:  Romy Parker; Jennifer Jelsma
Journal:  BMC Musculoskelet Disord       Date:  2010-01-04       Impact factor: 2.362

10.  An African ancestry-specific allele of CTLA4 confers protection against rheumatoid arthritis in African Americans.

Authors:  James M Kelley; Laura B Hughes; Jeffrey D Faggard; Maria I Danila; Monica H Crawford; Yuanqing Edberg; Miguel A Padilla; Hemant K Tiwari; Andrew O Westfall; Graciela S Alarcón; Doyt L Conn; Beth L Jonas; Leigh F Callahan; Edwin A Smith; Richard D Brasington; David B Allison; Robert P Kimberly; Larry W Moreland; Jeffrey C Edberg; S Louis Bridges
Journal:  PLoS Genet       Date:  2009-03-20       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.